← Back to headlines
UBS Adjusts Pharma Outlook, Raises Pfizer Price Target
UBS has revised its outlook for the pharmaceutical sector and increased its price target for Pfizer (PFE).
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
